For detailed cost planning across your full protocol, the peptide cost calculator can help you estimate total expenses based on your dose schedule and vial count
Find all our reported GAN DIO-MASH mouse studies here
Selected publications: Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes The Lancet, 2023
It activates two receptors simultaneously
If you told your doctor about these issues and were sent home without further testing, a referral, or a medication adjustment, your concerns may have been dismissed without justification
Retatrutide is studied as a multi-receptor agonist targeting GIP, GLP-1, and glucagon receptors, and is used in laboratory research focused on complex metabolic signaling